[
  {
    "date": "2023-12-30",
    "symbol": "INTI",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2023,
    "currentfiscalyearenddate": "--12-31",
    "entityfilenumber": "001-13467",
    "entityregistrantname": "Inhibitor Therapeutics, Inc.",
    "entitycentralindexkey": 1042418,
    "entitytaxidentificationnumber": "30-0793665",
    "entityincorporationstatecountrycode": "DE",
    "entityaddressaddressline1": "4905     South West Shore Blvd",
    "entityaddresscityortown": "Tampa",
    "entityaddressstateorprovince": "FL",
    "entityaddresspostalzipcode": "33611-3329",
    "cityareacode": 813,
    "localphonenumber": "864-2562",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "auditorfirmid": 677,
    "auditorname": "Cherry Bekaert LLP",
    "auditorlocation": "Tampa, Florida",
    "cashandcashequivalentsatcarryingvalue": 8839912,
    "prepaidexpenseandotherassetscurrent": 109243,
    "assetscurrent": 8949155,
    "assets": 8949155,
    "accountspayablecurrent": 33731,
    "accruedliabilitiescurrent": 631433,
    "liabilitiescurrent": 665164,
    "deferredrevenuenoncurrent": 3000000,
    "liabilities": 3665164,
    "commonstockvalue": 17202,
    "additionalpaidincapital": 54046845,
    "retainedearningsaccumulateddeficit": -48780056,
    "stockholdersequity": 5283991,
    "liabilitiesandstockholdersequity": 8949155,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 500000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 500000000,
    "commonstocksharesissued": 172023545,
    "commonstocksharesoutstanding": 172023545,
    "researchanddevelopmentexpense": 1381066,
    "generalandadministrativeexpense": 2023913,
    "operatingexpenses": 3404979,
    "operatingincomeloss": -3404979,
    "gainlossrelatedtolitigationsettlement": 14250000,
    "interestandotherincome": 378844,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -3026135,
    "netincomeloss": -3026135,
    "netincomelossavailabletocommonstockholdersbasic": -3026135,
    "earningspersharebasic": -0.02,
    "earningspersharediluted": -0.02,
    "weightedaveragenumberofsharesoutstandingbasic": 171950108,
    "weightedaveragenumberofdilutedsharesoutstanding": 171950108,
    "sharesoutstanding": 172023545,
    "stockissuedduringperiodvalueemployeebenefitplan": 23,
    "stockissuedduringperiodsharesemployeebenefitplan": 230411,
    "sharebasedcompensation": 13784,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 85343,
    "increasedecreaseinotheraccountspayableandaccruedliabilities": 397382,
    "netcashprovidedbyusedinoperatingactivities": -2700312,
    "repaymentsofnotespayable": 411000,
    "netcashprovidedbyusedinfinancingactivities": -411000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -3111312,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 8839912,
    "incometaxespaidnet": 53088,
    "minorityinterestownershippercentagebyparent": 1,
    "deferredrevenue": 3000000,
    "stockissuedduringperiodsharesrestrictedstockawardgross": 230411,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -635488,
    "incometaxreconciliationstateandlocalincometaxes": -131486,
    "incometaxreconciliationotheradjustments": 45096,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 721878,
    "deferredtaxassetsinprocessresearchanddevelopment": 742574,
    "deferredtaxassetsoperatinglosscarryforwards": 3516913,
    "deferredtaxassetsoperatinglosscarryforwardscapitalizedresearchexpense": 315028,
    "deferredtaxassetstaxcreditcarryforwardsincome": 760350,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 78336,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 34231,
    "deferredtaxassetsother": 6061,
    "deferredtaxassetsgross": 5453493,
    "deferredtaxassetsvaluationallowance": 5453493,
    "valuationallowancemethodologiesandassumptions": "Inaccordance with GAAP, it is required that a deferred tax asset be reduced by a valuation allowance if, based on the weight of availableevidence it is more likely than not (a likelihood of more than 50%) that some portion or all of the deferred tax assets will not be realized.",
    "percentageofdeferredtaxassetsvaluationallowance": 1,
    "netoperatinglossamountusedtooffsetagainsttaxableincome": 700000,
    "operatinglosscarryforwards": 14000000,
    "unrecognizedtaxbenefitsincometaxpenaltiesandinterestexpense": 17000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 2575646,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 0.09,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 93633,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangelowerrangelimit": 0.03,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeupperrangelimit": 0.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P6Y6M",
    "stockissuedduringperiodsharessharebasedcompensationforfeited": 205065189,
    "stockissuedduringperiodsharesconversionofunits": 17391306,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 4347827,
    "stockissuedduringperiodsharesnewissues": 10773815,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P3Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "stockgrantedduringperiodvaluesharebasedcompensation": 10000,
    "proceedsfromlicensefeesreceived": 40000,
    "royaltyexpense": 10000,
    "litigationsettlementexpense": 2000000,
    "litigationsettlementamountawardedtootherparty": 40000,
    "deferredtaxliabilities": 55000,
    "paymentsforrent": 25000
  },
  {
    "date": "2022-12-30",
    "symbol": "INTI",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentperiodenddate": "2022-12-31",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2022,
    "currentfiscalyearenddate": "--12-31",
    "entityfilenumber": "001-13467",
    "entityregistrantname": "Inhibitor Therapeutics, Inc.",
    "entitycentralindexkey": 1042418,
    "entitytaxidentificationnumber": "30-0793665",
    "entityincorporationstatecountrycode": "DE",
    "entityaddressaddressline1": "900                                             West Platt St Suite 200",
    "entityaddresscityortown": "Tampa",
    "entityaddressstateorprovince": "FL",
    "entityaddresspostalzipcode": "33606-2173",
    "cityareacode": 813,
    "localphonenumber": "864-2562",
    "security12gtitle": "Common stock, par value $.0001",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "icfrauditorattestationflag": "false",
    "auditorfirmid": 677,
    "auditorname": "Cherry Bekaert LLP",
    "auditorlocation": "Tampa, Florida",
    "cashandcashequivalentsatcarryingvalue": 11951224,
    "prepaidexpensecurrent": 23900,
    "assetscurrent": 11975124,
    "assets": 11975124,
    "accountspayablecurrent": 145161,
    "notespayablerelatedpartiesclassifiedcurrent": 411000,
    "accruedliabilitiescurrent": 122621,
    "liabilitiescurrent": 678782,
    "deferredrevenuenoncurrent": 3000000,
    "liabilities": 3678782,
    "commonstockvalue": 17179,
    "additionalpaidincapitalcommonstock": 54033084,
    "retainedearningsaccumulateddeficit": -45753921,
    "stockholdersequity": 8296342,
    "liabilitiesandstockholdersequity": 11975124,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 500000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 500000000,
    "commonstocksharesoutstanding": 171793134,
    "commonstocksharesissued": 171793134,
    "researchanddevelopmentexpense": 6150,
    "generalandadministrativeexpense": 651776,
    "operatingexpenses": 657926,
    "operatingincomeloss": -657926,
    "gainlossrelatedtolitigationsettlement": 12619492,
    "gainonforgivenessofcancellationonlegalfees": 223007,
    "interestexpense": 23234,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": 12161339,
    "incometaxexpensebenefit": 55109,
    "netincomeloss": 12106230,
    "preferredstockdividendsincomestatementimpact": 189042,
    "netincomelossavailabletocommonstockholdersbasic": 11917188,
    "earningspersharebasic": 0.03,
    "earningspersharediluted": 0.03,
    "weightedaveragenumberofsharesoutstandingbasic": 366183697,
    "weightedaveragenumberofdilutedsharesoutstanding": 367776961,
    "sharesoutstanding": 171793134,
    "dividendspreferredstock": 189042,
    "stockcancelledduringperiodvalue": -3960866,
    "stockcancelledduringperiodshares": -5797102,
    "gainrelatedtolitigationsettlement": 330830,
    "gainonforgivenessoflegalfees": 176889,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -4258,
    "increasedecreaseinotheraccountspayableandaccruedliabilities": 137829,
    "netcashprovidedbyusedinoperatingactivities": 11740598,
    "proceedsfromrelatedpartydebt": 180000,
    "netcashprovidedbyusedinfinancingactivities": 180000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 11920598,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 11951224,
    "cancellationofequity": 3981373,
    "accruedbutunpaiddividends": 189042,
    "gainlossonlegalsettlement": 14300000,
    "minorityinterestownershippercentagebyparent": 1,
    "deferredrevenue": 3000000,
    "cashfdicinsuredamount": 250000,
    "lineofcreditfacilitymaximumborrowingcapacity": 411000,
    "lineofcredit": 411000,
    "proceedsfromlinesofcredit": 180000,
    "currentfederaltaxexpensebenefit": 22850,
    "currentstateandlocaltaxexpensebenefit": 32259,
    "currentfederalstateandlocaltaxexpensebenefit": 55109,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": 2514182,
    "incometaxreconciliationstateandlocalincometaxes": 520196,
    "incometaxreconciliationotheradjustments": -70951,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": -2908318,
    "deferredtaxassetsinprocessresearchanddevelopment": 742574,
    "deferredtaxassetsoperatinglosscarryforwards": 3870413,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 78336,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 34231,
    "deferredtaxassetsother": 6061,
    "deferredtaxassetsgross": 4731615,
    "deferredtaxassetsvaluationallowance": 4731615,
    "valuationallowancemethodologiesandassumptions": "Inaccordance with GAAP, it is required that a deferred tax asset be reduced by a valuation allowance if, based on the weight of availableevidence it is more likely than not (a likelihood of more than 50 percent) that some portion or all of the deferred tax assets will notbe realized",
    "percentageofdeferredtaxassetsvaluationallowance": 1,
    "netoperatinglossamountusedtooffsetagainsttaxableincome": 37000,
    "netoperatinglossamountusedtooffsetagainstfuturetaxableincome": 700000,
    "operatinglosscarryforwards": 15300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 2575646,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 0.09,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 111774,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 10773815,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangelowerrangelimit": 0.03,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeupperrangelimit": 0.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y5M23D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 0.04,
    "stockissuedduringperiodsharessharebasedcompensationforfeited": 205065189,
    "stockissuedduringperiodsharesconversionofunits": 17391306,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 4347827,
    "stockissuedduringperiodsharesnewissues": 10773815,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P3Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "litigationsettlementexpense": 2000000,
    "litigationsettlementamountawardedtootherparty": 40000,
    "deferredtaxliabilities": 55000
  },
  {
    "date": "2021-12-30",
    "symbol": "INTI",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2021-12-31",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "documenttransitionreport": "false",
    "entityregistrantname": "Inhibitor Therapeutics, Inc.",
    "entityfilenumber": "001-13467",
    "entitycentralindexkey": 1042418,
    "currentfiscalyearenddate": "--12-31",
    "notradingsymbolflag": "true",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "documentannualreport": "true",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "security12gtitle": "Common stock",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "30-0793665",
    "entityaddressaddressline1": "449 South 12th Street",
    "entityaddressaddressline2": "Unit 1705",
    "entityaddresscityortown": "Tampa",
    "entityaddressstateorprovince": "FL",
    "entityaddresspostalzipcode": 33602,
    "cityareacode": 888,
    "localphonenumber": "841-6811",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "icfrauditorattestationflag": "false",
    "auditorname": "CHERRY BEKAERT LLP",
    "auditorfirmid": 677,
    "auditorlocation": "Tampa, Florida",
    "cashandcashequivalentsatcarryingvalue": 30626,
    "prepaidexpensecurrent": 28158,
    "assetscurrent": 58784,
    "assets": 58784,
    "accountspayablecurrent": 279842,
    "dividendspayablecurrent": 100823,
    "notespayablerelatedpartiesclassifiedcurrent": 231000,
    "interestpayablecurrent": 14965,
    "otherliabilitiescurrent": 53000,
    "liabilitiescurrent": 679630,
    "lineofcredit": 231000,
    "deferredrevenuenoncurrent": 3000000,
    "liabilities": 3679630,
    "preferredstockvalue": 3960866,
    "commonstockvalue": 37686,
    "additionalpaidincapitalcommonstock": 50051711,
    "retainedearningsaccumulateddeficit": -57671109,
    "stockholdersequity": -3620846,
    "liabilitiesandstockholdersequity": 58784,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 500000,
    "preferredstocksharesissued": 5797102,
    "preferredstocksharesoutstanding": 5797102,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 500000000,
    "commonstocksharesissued": 376858323,
    "commonstocksharesoutstanding": 376858323,
    "researchanddevelopmentexpense": 4905,
    "generalandadministrativeexpense": 320490,
    "operatingexpenses": 325395,
    "operatingincomeloss": -325395,
    "gainlossonsalesofloansnet": 41600,
    "interestincomeexpensenet": -14837,
    "netincomeloss": -298632,
    "dividendspreferredstockstock": 200001,
    "netincomelossavailabletocommonstockholdersbasicanddiluted": -498633,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 376247777,
    "sharesoutstanding": 5797102,
    "stockissuedduringperiodvaluestockdividend": 322,
    "commonstockdividendsshares": 3222450,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrestrictedstockunitsrequisiteserviceperiodrecognition": 37990,
    "dividendspreferredstock": 200001,
    "profitloss": -298632,
    "sharebasedcompensation": 37990,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -28542,
    "increasedecreaseinotheraccountspayableandaccruedliabilities": 53267,
    "netcashprovidedbyusedinoperatingactivities": -220433,
    "proceedsfromrelatedpartydebt": 176000,
    "netcashprovidedbyusedinfinancingactivities": 176000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -44433,
    "stockissued1": 200000,
    "accruedbutunpaiddividends": 100823,
    "royaltyrateonnetsales": 0.09,
    "fairvalueinputsroyaltyrate": 0.7,
    "sharesissuedpricepershare": 0.69,
    "numberoftimesofrespectiveinvestmentamount": 3,
    "equitymethodinvestmentownershippercentage": 0.5,
    "saleofstockconsiderationreceivedpertransaction": 5000000,
    "proceedsfromissuanceorsaleofequity": 3000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofadditionalsharesauthorized": 11000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 32583475,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 43583475,
    "cashfdicinsuredamount": 250000,
    "deferredrevenue": 3000000,
    "lineofcreditfacilityremainingborrowingcapacity": 75000,
    "lineofcreditfacilityperiodicpayment": 25000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -62713,
    "incometaxreconciliationstateandlocalincometaxes": -12976,
    "incometaxreconciliationotheradjustments": -905,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 76594,
    "deferredtaxassetsinprocessresearchanddevelopment": 742574,
    "deferredtaxassetsoperatinglosscarryforwards": 6685183,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 171884,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 34231,
    "deferredtaxassetsother": 6061,
    "deferredtaxassetsgross": 7639933,
    "deferredtaxassetsvaluationallowance": 7639933,
    "percentageofdeferredtaxassetsvaluationallowance": 1,
    "valuationallowancemethodologiesandassumptions": "In accordance with GAAP, it is required that a deferred tax asset be reduced by a valuation allowance if, based on the weight of available evidence it is more likely than not (a likelihood of more than 50 percent) that some portion or all of the deferred tax assets will not be realized",
    "valuationallowanceassumptions": 0.5,
    "operatinglosscarryforwards": 26400000,
    "netoperatinglossamountusedtooffsetagainsttaxableincome": 35000,
    "operatinglosscarryforwardsexpirationdate": "2021-12-31",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 13349461,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 0.05,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 1072144,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingpricelowerrange": 0.03,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingpriceupperrange": 0.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P9Y3M10D",
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsaggregateintrinsicvalue": 1072144,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P3Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 1,
    "minimumspecifiedvotingstockpercentageunderincentivestockplan": 0.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "classofwarrantorrightoutstanding": 4347827,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 0.275,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": "P1Y2M19D"
  },
  {
    "date": "2020-12-30",
    "symbol": "INTI",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "Inhibitor Therapeutics, Inc.",
    "entitycentralindexkey": 1042418,
    "currentfiscalyearenddate": "--12-31",
    "notradingsymbolflag": "true",
    "entitycurrentreportingstatus": "Yes",
    "entityshellcompany": "false",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityaddressstateorprovince": "FL",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "security12gtitle": "Common stock",
    "icfrauditorattestationflag": "true",
    "cashandcashequivalentsatcarryingvalue": 75059,
    "prepaidexpensecurrent": 32292,
    "assetscurrent": 107351,
    "otherassetsnoncurrent": 24408,
    "assets": 131759,
    "accountspayablecurrent": 269416,
    "dividendspayablecurrent": 100822,
    "notespayabletobankcurrent": 30044,
    "otherliabilitiescurrent": 25124,
    "liabilitiescurrent": 425406,
    "notespayabletobanknoncurrent": 11556,
    "lineofcredit": 55000,
    "deferredrevenuenoncurrent": 3000000,
    "liabilities": 3491962,
    "preferredstockvalue": 3960866,
    "commonstockvalue": 37364,
    "additionalpaidincapitalcommonstock": 49814043,
    "retainedearningsaccumulateddeficit": -57172476,
    "stockholdersequity": -57172476,
    "liabilitiesandstockholdersequity": 131759,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 2253623,
    "preferredstocksharesissued": 5797102,
    "preferredstocksharesoutstanding": 5797102,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 500000000,
    "commonstocksharesissued": 373635873,
    "commonstocksharesoutstanding": 373635873,
    "researchanddevelopmentexpense": 185294,
    "generalandadministrativeexpense": 873703,
    "operatingexpenses": 1058997,
    "operatingincomeloss": -1058997,
    "interestincomeexpensenet": 1068,
    "netincomeloss": -1057929,
    "dividendspreferredstockstock": 200548,
    "netincomelossavailabletocommonstockholdersbasicanddiluted": -1258477,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 371927734,
    "sharesoutstanding": 373635873,
    "stockissuedduringperiodvaluestockdividend": 200548,
    "commonstockdividendsshares": 3189688,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrestrictedstockunitsrequisiteserviceperiodrecognition": 228861,
    "dividendspreferredstock": 200548,
    "profitloss": -1057929,
    "sharebasedcompensation": 228861,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -39450,
    "increasedecreaseinotheraccountspayableandaccruedliabilities": -35739,
    "netcashprovidedbyusedinoperatingactivities": -825357,
    "proceedsfromnotespayable": 41600,
    "proceedsfromrelatedpartydebt": 55000,
    "netcashprovidedbyusedinfinancingactivities": 96600,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -728757,
    "stockissued1": 200548,
    "accruedbutunpaiddividends": 100822,
    "royaltyrateonnetsales": 0.09,
    "fairvalueinputsroyaltyrate": 0.7,
    "sharesissuedpricepershare": 0.69,
    "numberoftimesofrespectiveinvestmentamount": 3,
    "equitymethodinvestmentownershippercentage": 0.5,
    "saleofstockconsiderationreceivedpertransaction": 2000000,
    "proceedsfromissuanceorsaleofequity": 3000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofadditionalsharesauthorized": 11000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 6624000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 8346776,
    "cashfdicinsuredamount": 250000,
    "deferredrevenue": 3000000,
    "lineofcreditfacilityremainingborrowingcapacity": 75000,
    "lineofcreditfacilityperiodicpayment": 25000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -222165,
    "incometaxreconciliationstateandlocalincometaxes": -45967,
    "incometaxreconciliationotheradjustments": -13668,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 281800,
    "deferredtaxassetsinprocessresearchanddevelopment": 742574,
    "deferredtaxassetsoperatinglosscarryforwards": 6608114,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 190515,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 34231,
    "deferredtaxassetsother": 6060,
    "deferredtaxassetsgross": 7581494,
    "deferredtaxassetsvaluationallowance": 7581494,
    "percentageofdeferredtaxassetsvaluationallowance": 1,
    "valuationallowancemethodologiesandassumptions": "In accordance with GAAP, it is required that a deferred tax asset be reduced by a valuation allowance if, based on the weight of available evidence it is more likely than not (a likelihood of more than 50 percent) that some portion or all of the deferred tax assets will not be realized.\t",
    "valuationallowanceassumptions": 0.5,
    "operatinglosscarryforwards": 26100000,
    "netoperatinglossamountusedtooffsetagainsttaxableincome": 35000,
    "operatinglosscarryforwardsexpirationdate": "2020-12-31",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 627000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 0.33,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 0.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 14587,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingpricelowerrange": 0.31,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingpriceupperrange": 0.33,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y5M15D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 14587,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangelowerrangelimit": 0.31,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeupperrangelimit": 0.33,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofoutstandingoptions": 6055461,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageremainingcontractualterm2": "P9Y3M25D",
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageexerciseprice1": 0.05,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsaggregateintrinsicvalue": 14587,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 4500000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 4500000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 2208685,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedexercisepricepershare": 0.05,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P3Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 1.1,
    "minimumspecifiedvotingstockpercentageunderincentivestockplan": 0.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P5Y",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 40000,
    "classofwarrantorrightoutstanding": 50270563,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 0.13,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": "P6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 0.03
  },
  {
    "date": "2019-12-30",
    "symbol": "INTI",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2019-12-31",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "Inhibitor Therapeutics, Inc.",
    "entitycentralindexkey": 1042418,
    "currentfiscalyearenddate": "--12-31",
    "notradingsymbolflag": "true",
    "entitycurrentreportingstatus": "Yes",
    "entityshellcompany": "false",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityaddressstateorprovince": "FL",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "security12gtitle": "Common stock",
    "cashandcashequivalentsatcarryingvalue": 803816,
    "prepaidexpensecurrent": 42450,
    "assetscurrent": 846266,
    "otherassetsnoncurrent": 53700,
    "assets": 899966,
    "accountspayablecurrent": 315940,
    "dividendspayablecurrent": 100822,
    "otherliabilitiescurrent": 14339,
    "liabilitiescurrent": 431101,
    "deferredrevenuenoncurrent": 3000000,
    "liabilities": 3431101,
    "preferredstockvalue": 3960866,
    "commonstockvalue": 37045,
    "additionalpaidincapitalcommonstock": 49384953,
    "retainedearningsaccumulateddeficit": -55913999,
    "stockholdersequity": -55913999,
    "liabilitiesandstockholdersequity": 899966,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 2253623,
    "preferredstocksharesissued": 5797102,
    "preferredstocksharesoutstanding": 5797102,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 500000000,
    "commonstocksharesissued": 370446185,
    "commonstocksharesoutstanding": 370446185,
    "researchanddevelopmentexpense": 1208075,
    "generalandadministrativeexpense": 1539821,
    "operatingexpenses": 2747896,
    "operatingincomeloss": -2747896,
    "interestincomeexpensenet": 14540,
    "netincomeloss": -2733356,
    "dividendspreferredstockstock": 200000,
    "netincomelossavailabletocommonstockholdersbasicanddiluted": -2933356,
    "earningspersharebasicanddiluted": -0.01,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 370432295,
    "sharesoutstanding": 370446185,
    "stockissuedduringperiodvaluestockdividend": 99946,
    "commonstockdividendsshares": 362121,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrestrictedstockunitsrequisiteserviceperiodrecognition": 269924,
    "dividendspreferredstock": 200000,
    "profitloss": -2733356,
    "sharebasedcompensation": 269924,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -28138,
    "increasedecreaseinotheraccountspayableandaccruedliabilities": -270425,
    "netcashprovidedbyusedinoperatingactivities": -2705719,
    "proceedsfromadvancesofroyaltiesrelatedparty": 2500000,
    "paymentsofdividends": 99178,
    "netcashprovidedbyusedinfinancingactivities": 2400822,
    "cashandcashequivalentsperiodincreasedecrease": -304897,
    "stockissued1": 99946,
    "accruedbutunpaiddividends": 100822,
    "royaltyrateonnetsales": 0.09,
    "fairvalueinputsroyaltyrate": 0.7,
    "sharesissuedpricepershare": 0.69,
    "numberoftimesofrespectiveinvestmentamount": 3,
    "equitymethodinvestmentownershippercentage": 0.5,
    "saleofstockconsiderationreceivedpertransaction": 5000000,
    "proceedsfromissuanceorsaleofequity": 3000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofadditionalsharesauthorized": 11000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 6624000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 17624000,
    "cashfdicinsuredamount": 250000,
    "cashuninsuredamount": 300000,
    "deferredrevenue": 3000000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -574005,
    "incometaxreconciliationstateandlocalincometaxes": -112934,
    "incometaxreconciliationotheradjustments": 40085,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 646854,
    "deferredtaxassetsinprocessresearchanddevelopment": 736325,
    "deferredtaxassetsoperatinglosscarryforwards": 6425461,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 339052,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 33943,
    "deferredtaxassetsother": 2742,
    "deferredtaxassetsgross": 7537523,
    "deferredtaxassetsvaluationallowance": 7537523,
    "percentageofdeferredtaxassetsvaluationallowance": 1,
    "valuationallowancemethodologiesandassumptions": "In accordance with GAAP, it is required that a deferred tax asset be reduced by a valuation allowance if, based on the weight of available evidence it is more likely than not (a likelihood of more than 50 percent) that some portion or all of the deferred tax assets will not be realized.",
    "valuationallowanceassumptions": 0.5,
    "operatinglosscarryforwards": 25600000,
    "netoperatinglossamountusedtooffsetagainsttaxableincome": 35000,
    "operatinglosscarryforwardsexpirationdate": "2019-12-31",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 2208685,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 1616842,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 0.33,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 0.07,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 0.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 1260,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingpricelowerrange": 0.31,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingpriceupperrange": 0.33,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y5M15D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 1260,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangelowerrangelimit": 0.31,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeupperrangelimit": 0.33,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofoutstandingoptions": 2794000,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageremainingcontractualterm2": "P8Y5M15D",
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageexerciseprice1": 0.33,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 2208685,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 3195527,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 1671000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 1331842,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedexercisepricepershare": 0.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvaluenonvested": 1260,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P3Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 1.1,
    "minimumspecifiedvotingstockpercentageunderincentivestockplan": 0.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P5Y",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 10000,
    "classofwarrantorrightoutstanding": 54618390,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 0.14,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": "P1Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 0.05
  }
]